STEVENS CAPITAL MANAGEMENT LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$33,000
-15.4%
15,859
+23.8%
0.00%
-50.0%
Q4 2015$39,000
+5.4%
12,814
-14.6%
0.00%0.0%
Q3 2015$37,000
-28.8%
15,003
-7.6%
0.00%0.0%
Q2 2015$52,0000.0%16,242
-39.7%
0.00%0.0%
Q3 2014$52,00026,9370.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders